BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc.
Read moreAlbireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
![](https://mybestmedicine.com/wp-content/uploads/sites/13/2018/04/QwmmJcQFqNwVkMZDKDnn-820x360.jpg)
mybestmedicine.com
Home »
BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc.
Read more